Prevention of Gut Barrier Dysfunction During Acute Massive Blood Loss (Experimental Study)

Prevention of Gut Barrier Dysfunction During Acute Massive Blood Loss (Experimental Study)

Purpose of the study: to investigate the influence of hypovolemia correction by infusion of malate-containing preparations and subsequent glutamine-enriched nutritional support on the maintenance of gut barrier and overhydration in animals with acute massive blood loss/ Materials and methods. Blood...

Full description

Bibliographic Details
Main Authors:	A. Y. Yakovlev, G. A. Boyarinov, D. V. Ryabikov, M. A. Ryabikova, D. M. Protasov, I. V. Mukhina
Format:	Article
Language:	Russian
Published:	Russian Academy of Medical Sciences 2019-09-01
Series:	Obŝaâ Reanimatologiâ
Subjects:	blood loss lipopolysaccharide presepsin glutamine malate
Online Access:	https://www.reanimatology.com/rmt/article/view/1791

Similar Items

Can presepsin uniformly respond to various pathogens? - an in vitro assay of new sepsis marker -
by: Yusuke Koizumi, et al.
Published: (2020-06-01)

The role of presepsin in the diagnosis and assessment of severity of sepsis and severe pneumonia
by: E A TItova, et al.
Published: (2018-11-01)

Usefulness of Presepsin (sCD14-ST) in diagnosis of Infective Endocarditis - preliminary results of an observational study / Utilitatea presepsinului (sCD14-ST) în Endocardita Infecțioasă –rezultate preliminare ale unui studiu observațional
by: Topan Adriana, et al.
Published: (2015-08-01)

Biostimulant Effect and Biochemical Response in Lettuce Seedlings Treated with A <i>Scenedesmus quadricauda</i> Extract
by: Ivana Puglisi, et al.
Published: (2020-01-01)

Purulent-septic complications of acute necrotizing pancreatitis: prognosis of development and early diagnosis
by: O. V. Rotar, et al.
Published: (2020-10-01)

The Association between Dynamic Changes in Serum Presepsin Levels and Mortality in Immunocompromised Patients with Sepsis: A Prospective Cohort Study
by: Jongmin Lee, et al.
Published: (2021-01-01)

Presepsin as a sepsis biomarker
by: K. A. Trunova
Published: (2018-05-01)

PRESEPSIN AS THE EARLY MARKER OF PURULENT SEPTIC COMPLICATIONS IN PATIENTS WITH SEVERE ACUTE PANCREATITIS
by: N. N. Salina, et al.
Published: (2018-04-01)

Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates
by: Halil Değirmencioğlu, et al.
Published: (2019-08-01)

Plasma concentration of presepsin and its relationship to the diagnosis of infections in multiple trauma patients admitted to intensive care
by: Monica Sparacino, et al.
Published: (2017-07-01)

Role of Presepsin in Predicting ShortTerm Patient’s Status Changes and Preventing Excessive Antimicrobial Therapy in Patients with Nosocomial Infections
by: Zagorodnikova K.A., et al.
Published: (2015-08-01)

The long noncoding RNA MALAT1 modulates adipose loss in cancer-associated cachexia by suppressing adipogenesis through PPAR-γ
by: Jun Han, et al.
Published: (2021-03-01)

PLACE OF PRESEPSIN IN THE SCREENING FOR INFECTIONS IN THE CRITICALLY ILL PATIENTS
by: A. Afanasiev, et al.
Published: (2018-08-01)

Foliar Spray Application of <i>Chlorella vulgaris</i> Extract: Effect on the Growth of Lettuce Seedlings
by: Emanuele La Bella, et al.
Published: (2021-02-01)

PRESEPSIN AND PROCALCITONIN VALUES TO DETERMINE THE PROGNOSIS OF UROSEPSIS
by: Sofyan Rais Addin, et al.
Published: (2018-07-01)

Presepsin as a Potential Prognostic Marker for Sepsis According to Actual Practice Guidelines
by: Alice Nicoleta Drăgoescu, et al.
Published: (2021-12-01)

Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria
by: Wen MY, et al.
Published: (2019-06-01)

Particular paraclinical indices in newborn sepsis patients whose parents constantly lived in different environmental conditions
by: Olena Vasylivna Vlasova
Published: (2020-04-01)

Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis
by: Jong Eun Park, et al.
Published: (2021-08-01)

Can a Presepsin (Scd14-St) Obtained from Tracheal Aspirate Be a Biomarker for Early- Onset Neonatal Sepsis
by: Savic Dragana, et al.
Published: (2020-09-01)

Presepsin: A promising biomarker for the detection of bacterial infections
by: Mohammad Yousef Memar, et al.
Published: (2019-03-01)

Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients
by: Elham A. Hassan, et al.
Published: (2019-02-01)

Cerebrospinal Fluid Presepsin as a Marker of Nosocomial Infections of Central Nervous System
by: S. A. Abudeyev, et al.
Published: (2019-04-01)

Presepsin level as risk factor for mortality in premature infants with neonatal sepsis
by: Muhammad Ifan Romli, et al.
Published: (2021-06-01)

Evaluation of the Diagnostic and Prognostic Value of CSF Presepsin Levels in Patients with Postneurosurgical Ventriculitis/Meningitis
by: Zhang G, et al.
Published: (2021-07-01)

Neonatal sepsis
by: Angelica Dessì, et al.
Published: (2014-10-01)

A hemodialysis patient with Mycobacterium avium complex pericarditis in which remarkable presepsin elevation was not accompanied by procalcitonin elevation
by: Jun Shiota
Published: (2020-04-01)

L-Glutamin-Induced Inhibition of Endotoxemia by Reducing Pre-Inflammatory Cytokines, Nitric Oxide, and CD40 Expression
by: Yaser Jafari khataylou, et al.
Published: (2020-10-01)

Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study
by: Sergey A. Abudeev, et al.
Published: (2018-02-01)

Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication
by: Mohamed El-Saied El-Shafie, et al.
Published: (2017-04-01)

Choice of an Infusion Agent for the Prevention of Multiple Organ Dysfunction in Acute Massive Blood Loss (Experimental Study)
by: A. Yu. Yakovlev, et al.
Published: (2010-06-01)

Glutamine-Glutamate Cycle Flux Is Similar in Cultured Astrocytes and Brain and Both Glutamate Production and Oxidation Are Mainly Catalyzed by Aspartate Aminotransferase
by: Leif Hertz, et al.
Published: (2017-02-01)

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis
by: Seo Hee Yoon, et al.
Published: (2019-08-01)

Academy of Emergency Medicine and Care-Society of Clinical Biochemistry and Clinical Molecular Biology consensus recommendations for clinical use of sepsis biomarkers in the emergency department
by: Giuseppe Lippi, et al.
Published: (2017-11-01)

Presepsin: a new marker of catheter related blood stream infections in pediatric patients
by: Javier, Rivera-Morán, et al.
Published: (2018)

Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review
by: Andrea Piccioni, et al.
Published: (2021-07-01)

Role of biomarkers in the diagnosis of bacterial infections in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-07-01)

The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions
by: Naoki Watanabe, et al.
Published: (2018-11-01)

Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department
by: Carpio, Ricardo, et al.
Published: (2015)

Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial
by: Carlo Pietrasanta, et al.
Published: (2021-05-01)